MESA LABS DECLARES QUARTERLY DIVIDEND

NeurAxis Inc. to Participate in the Lytham Partners 2025 Investor Healthcare Summit on January 13, 2025

Rendever Launches Alcove Sanctuary: A New VR Application Featuring an AI Family Companion

Oculis Announces Positive OCS-05 Phase 2 ACUITY Trial in Acute Optic Neuritis, Met Primary Safety Endpoint and Key Secondary Efficacy Endpoints Opening Development Pathways as a Potential First-in-Class Neuroprotective Therapy

Oculis Publishes Notification of Major Changes in Voting Rights

Palisade Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Bionano Announces $10 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules

ACC Medlink Solidifies Leadership with 20% Expansion to Fleet of Mercedes Sprinter Vans

Psychiatric Times® celebrates 40 years at the forefront of psychiatry

Energroup Holdings Corp (OTC: ENHD) to Acquire Cocannco Inc.

NeuroOne® Announces Virtual Investor Webinar on January 9, 2025 at 11:00 a.m. EST

Safety Shot Launches Revolutionary On-the-Go Stick Packs, Poised to Disrupt the $2 Billion Wellness Market

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Agios to Present at the 43rd Annual J.P. Morgan Healthcare Conference on January 15, 2025

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Lifecore Biomedical Reports Second Quarter Fiscal 2025 Financial Results and Provides Corporate Update

RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference

NEXGEL Appoints Joseph F. McGuire as Chief Financial Officer

Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain

GCAN to Explore Strategic Alternatives in Artificial Intelligence and Quantum Computing

SELLAS to Host Corporate Update Call on January 8, 2025, at 9:00 am ET

Clearmind Medicine Granted Patent for Binge Behavior Treatment by the Macau International Intellectual Property Office

HUTCHMED Announces NDA Acceptance in China with Priority Review Status for ORPATHYS® and TAGRISSO® Combination in Lung Cancer Patients with MET amplification After Progression on First-Line EGFR Inhibitor Therapy

HUTCHMED Announces US$608 million Divestment of Non-Core Joint Venture

Bionano Announces Amendment to Senior Secured Convertible Debentures in Debt Restructuring that Improves Cash Runway

Veru Announces the Sale of the FC2 Female Condom® (Internal Condom) Business

Vireo Growth Inc. Announces Closing of Oversubscribed US$81 Million Equity Securities Offering

Cocrystal Pharma to Extend Phase 2a Influenza Challenge Study with Oral PB2 inhibitor CC-42344

Making Cancer Drugs Safer: CellMosaic CEO to Host Live Investment Webinar

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Oncotelic Therapeutics Implements PDAOAI Platform

Galera Therapeutics completes acquisition of Nova Pharmaceuticals

FibroBiologics Closes Second $5 Million Tranche of $25 Million Financing

Telix Files TLX250-CDx (Zircaix®) BLA for Kidney Cancer Imaging

Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders

Vincerx Pharma Enters into a Binding Term Sheet for a Strategic Merger with Oqory, Inc.

LYNN STOCKWELL ENTERS INTO A RESTRUCTURING SECURITY AGREEMENT (“RSA”) WITH BRIGHT GREEN CORPORATION AND ASSUMES THE ROLE OF EXECUTIVE CHAIR AND CEO.

Outlook Therapeutics® Reports Financial Results for Fiscal Year 2024 and Provides Corporate Update

WEED Inc. President and CEO Releases Letter to Shareholders

Recover Red Introduces Portable Red Light Therapy Solution: The Power Stack

Clearmind Medicine Receives IRB Approval for its FDA-Regulated Clinical Trial

Patent Tech-AI Law NGO serving disabled people who can't afford attorney (Quantum computers meets law sector): VRN News

Aster Guardians Global Nursing Award 2025 worth US$250,000 now open for nominations worldwide

CVRx to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Solid Biosciences Added to the Nasdaq Biotechnology Index

AVITA Medical Announces FDA Approval of RECELL GO mini, Optimizing Treatment for Smaller Wounds

Guardion Health Sciences Announces Declaration of Cash Distribution

Biofrontera Inc. Announces 100 RhodoLED® XL Machines Now Placed in US Market

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Patients as Young as 2 Years Old

Syntekabio to Showcase AI-Driven Drug Discovery Solutions at Biotech Showcase 2025

Comprehensive Healthcare Leader Joins NAMI Washington Board of Directors

Balt secures €355 million to refinance its debt and accelerate its growth

HNL Lab Medicine’s Angel Tree Program Brings Holiday Magic to Families in Need

Compass Health Celebrates Second Donation from Longtime Partner for its State-of-the-Art Regional Center for Intensive Behavioral Health Needs

Quoin Pharmaceuticals Announces Pricing of $6.8 Million Public Offering

Merit Medical Announces FDA Approval of the WRAPSODY Cell-Impermeable Endoprosthesis

Nxera Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Mangoceuticals, Inc. Completes Acquisition of Mushroom-Based Wellness and Innovations Patent